These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9864827)

  • 1. [Serological properties of HIV-1 isolates from the focus of an epidemic in the Gomel region of the Belarus Republic (1996)].
    Shchelkanov MIu; Iaroslavtseva NG; Iudin AN; Mirskov IuA; Eremin VF; Titov LP; Rytik PG; Karamov EV
    Vopr Virusol; 1998; 43(5):220-9. PubMed ID: 9864827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increase in the serotypical heterogeneity in HIV-1 in Svetlogorsk focus 1 year after the start of an epidemic].
    Shchelkanov MIu; Iudin AN; Eremin VF; Gadynskaia NI; Iaroslavtseva NG; Karamov EV
    Vopr Virusol; 1999; 44(4):174-7. PubMed ID: 10500987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV-1 serotyping of V3-mimicking peptides circulating in the Republic of Tajikistan among intravenous drug users].
    Burunova VV; Shchelkanov MIu; Tishkova FKh; Starikov NS; Pazilin AS; Belobrova EA; Petrenko MS; Iudin AN; Samuilov VD; Garaev MM; L'vov DK
    Vopr Virusol; 2004; 49(4):30-9. PubMed ID: 15293509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HIV type 1 epidemic in Belarus: predominance of Eastern European subtype A strains and circulation of subtype B viruses.
    Lazouskaya NV; Eremin VF; Adema KW; Gasich EL; Baan E; Lukashov VV
    AIDS Res Hum Retroviruses; 2005 Sep; 21(9):830-3. PubMed ID: 16218809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand.
    Pau CP; Lee-Thomas S; Auwanit W; George JR; Ou CY; Parekh BS; Granade TC; Holloman DL; Phillips S; Schochetman G
    AIDS; 1993 Mar; 7(3):337-40. PubMed ID: 8471195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus.
    Lukashov VV; Karamov EV; Eremin VF; Titov LP; Goudsmit J
    AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1299-303. PubMed ID: 9764916
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization.
    Cheingsong-Popov R; Osmanov S; Pau CP; Schochetman G; Barin F; Holmes H; Francis G; Ruppach H; Dietrich U; Lister S; Weber J
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):311-8. PubMed ID: 9519892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.
    Sherefa K; Sällberg M; Sönnerborg A
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1551-6. PubMed ID: 7534097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization.
    Cheingsong-Popov R; Lister S; Callow D; Kaleebu P; Beddows S; Weber J
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1379-86. PubMed ID: 7888191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological approaches to subtyping of HIV-1 in injecting drug users in Russia: evidence of subtype homogeneity at the main sites of the epidemic.
    Bobkova MR; Kazennova EV; Selimova LM; Buravtsova EV; Lister S; Prilipov AG; Weber JN; Pokrovsky VV; Bobkov AF
    Int J STD AIDS; 2001 Jan; 12(1):34-40. PubMed ID: 11177480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of HIV-1 in the former Soviet Union: analysis of env V3 sequences and their correlation with epidemiologic data.
    Bobkov A; Garaev MM; Rzhaninova A; Kaleebu P; Pitman R; Weber JN; Cheingsong-Popov R
    AIDS; 1994 May; 8(5):619-24. PubMed ID: 8060542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of HIV-1 V3 serotyping in studying the HIV-1 epidemic in South Africa.
    Cheingsong-Popov R; Williamson C; Lister S; Morris L; van Harmelen J; Bredell H; Wood R; Sonnenberg P; van der Ryst E; Martin D; Weber J
    AIDS; 1998 May; 12(8):949-50. PubMed ID: 9631149
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serotypical stratification of HIV-1 in populations of intravenous drug users in the south/southwestern Ukraine].
    Shchelkanov MIu; Iaroslavtseva NG; Nabatov AA; Masharskiĭ AE; Iudin AN; Mirskov IuA; Chentsova NP; Kobyshcha IuV; Kozlov AP; Karamov EV
    Vopr Virusol; 1998; 43(4):176-82. PubMed ID: 9791884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. V3 serological subtyping of human immunodeficiency virus type 2 infection is not relevant.
    Plantier JC; Damond F; Souquières S; Brun-Vézinet F; Simon F; Barin F
    J Clin Microbiol; 2001 Oct; 39(10):3803-7. PubMed ID: 11574625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania.
    Lukashov VV; Cornelissen MT; Goudsmit J; Papuashvilli MN; Rytik PG; Khaitov RM; Karamov EV; de Wolf F
    AIDS; 1995 May; 9(5):435-9. PubMed ID: 7639968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of human immunodeficiency virus type 1 serotypes in northern Tanzania: a retrospective study.
    Nyombi BM; Nkya W; Barongo L; Bjune G; Kristiansen KI; Müller F; Holm-Hansen C
    APMIS; 2008 Jun; 116(6):507-14. PubMed ID: 18754325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiological evolution of HIV-1 subtypes B and E among heterosexuals and injecting drug users in Thailand, 1992-1997.
    Limpakarnjanarat K; Ungchusak K; Mastro TD; Young NL; Likhityingvara C; Sangwonloy O; Weniger BG; Pau CP; Dondero TJ
    AIDS; 1998 Jun; 12(9):1108-9. PubMed ID: 9662211
    [No Abstract]   [Full Text] [Related]  

  • 18. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of antibody response against the V3 loop in children with vertically acquired immunodeficiency virus type 1 (HIV-1) infection.
    De Rossi A; Zanotto C; Mammano F; Ometto L; Del Mistro A; Chieco-Bianchi L
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):221-8. PubMed ID: 7682425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.
    Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD
    AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.